Medical Electrodes Market, By Product Type (Surface Electrodes and Needle Electrodes), By Usability (Disposable Medical Electrodes and Reusable Medical Electrodes), By Modality Type (Electrocardiography (ECG), Electroencephalography (EEG), Electromyography (EMG), Brainstem Auditory Evoked Potentials (BAEPS), and Other Modality Types), By Application (Cardiology, Neurophysiology, Sleep Disorders, Intraoperative Monitoring, and Other Applications), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030

The medical electrode market was valued at US$1.63 billion in 2020 and is projected to grow at a compound annual growth rate (CAGR) of 4.3% to reach US$2.49 billion by 2030.

Medical electrodes convert the energy of the body's ionic currents into electrical currents to be examined, magnified, and utilized for various medical diagnostic purposes. Lead, metal and an electrode conducting plate make up the medical electrode. Medical electrodes are used in conjunction with monitoring systems to diagnose and continuously monitor patients with various illnesses, including issues related to neurology and cardiology. The medical field uses a variety of electrodes, including transcutaneous electrical nerve stimulation (TENS) electrodes, fetal scalp electrodes, electroencephalography electrodes, and electrocardiography (ECG) electrodes—worldwide pacemaker electrodes, et al. An electrode could be a medical device that converts ionic current energy into electrical current inside the body, which can then be amplified to treat and diagnose several illnesses, including potentially fatal ones. The number of severe and chronic disease statistics has increased exponentially in the last ten years due to rising global expectations and population growth. The average yearly death rate from neurological disorders was 18.8/100,000; this included 7.1/100,000 from Alzheimer's disease and other dementias and 1.7/100,000 from paralysis agitans. In a table showing the prevalence of all diseases measured in years lived with disability, migraine ranked eighth, epilepsy ranked twentieth, and Alzheimer's disease ranked twenty-fourth.